Kun E, Kirsten E, Sharma M L
Proc Natl Acad Sci U S A. 1977 Nov;74(11):4942-6. doi: 10.1073/pnas.74.11.4942.
A soluble extract of the mitochondrial compartment composed of the inner membrane and matrix catalyzes the enzymatic synthesis and hydrolysis of the 1:1 adduct of citric acid and glutathione. The adduct was identified as the thioester by isolation with single and double isotope labeling ([(14)C]citric acid and [(35)S]glutathione) and by conversion to the monohydroxamate of citric acid and comparison with the synthetic product by thin layer chromatography and high voltage electrophoresis. The enzymatic formation of the thioester (pH optimum 7.39 at 30 degrees ) requires oxidized glutathione and citrate; both substrates exhibit a Michaelis-Menten kinetics. During the enzymatic reaction equimolar quantities of thioester and glutathione sulfinic acid are formed. After gel filtration or salt fractionation the enzyme system requires Mn(2+) (or Mg(2+), which is less effective) for maximal activity. When extracts of mitoplast are tested, the time course of reaction is biphasic due to the rapid synthesis of the product by the thioester-forming system (molecular weight 171,000) followed by its decay by the hydrolase (molecular weight 71,000). The two systems were separated by molecular filtration on Sephadex G-200 and by precipitation with (NH(4))(2)SO(4). The thioester-forming system is inhibited by preincubation with 0.5 mM mersalyl. Other inhibitors are 1,2,3-propane tricarboxylic acid, 10 mM Ca(2+), 200 mM K(+), and the free radical trapping agent, phenazine methosulfate. The citrate-glutathione thioester formation is irreversibly and specifically inhibited by (-)erythrofluorocitrate (50% inhibition at 25 pmol of added fluorocitrate per mg of protein), which forms a trichloroacetic acid-stable adduct with the enzyme protein (at 50% inhibition, 0.8 pmol is bound to 1 mg of protein). Synthesis of malyl-glutathione thioester by inner membrane vesicles is selectively inhibited by (-)erythrofluoromalate.
由内膜和基质组成的线粒体区室的可溶性提取物催化柠檬酸与谷胱甘肽1:1加合物的酶促合成及水解。通过单同位素和双同位素标记([¹⁴C]柠檬酸和[³⁵S]谷胱甘肽)分离以及将其转化为柠檬酸单异羟肟酸酯,并通过薄层色谱和高压电泳与合成产物进行比较,确定该加合物为硫酯。硫酯的酶促形成(30℃时最适pH为7.39)需要氧化型谷胱甘肽和柠檬酸盐;两种底物均呈现米氏动力学。在酶促反应过程中,会形成等摩尔量的硫酯和谷胱甘肽亚磺酸。经过凝胶过滤或盐分级分离后,酶系统需要Mn²⁺(或效果稍差的Mg²⁺)才能达到最大活性。当测试线粒体提取物时,反应的时间进程是双相的,这是由于硫酯形成系统(分子量171,000)快速合成产物,随后被水解酶(分子量71,000)降解。通过在Sephadex G - 200上进行分子过滤以及用硫酸铵沉淀,将这两个系统分离。硫酯形成系统在与0.5 mM汞撒利预孵育后受到抑制。其他抑制剂包括1,2,3 - 丙烷三羧酸、10 mM Ca²⁺、200 mM K⁺以及自由基捕获剂吩嗪硫酸甲酯。( - )赤藓型氟柠檬酸不可逆且特异性地抑制柠檬酸 - 谷胱甘肽硫酯的形成(每毫克蛋白质加入25 pmol氟柠檬酸时抑制50%),它与酶蛋白形成一种三氯乙酸稳定的加合物(在50%抑制时,0.8 pmol与1毫克蛋白质结合)。内膜囊泡合成苹果酰 - 谷胱甘肽硫酯受到( - )赤藓型氟苹果酸的选择性抑制。